Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
PaperCitations, authors & open-access status
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆ is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 211 citations, 2021 year and hybrid oa status.
211
Citations
2021
Year
hybrid
OA Status